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There has been a dramatic expansion of biomedical research in 
low- and middle-income countries (LMICs) in the last few decades, 
much of it designed in high-income countries, and the workload 
of research ethics committees (RECs) and/or institutional review 
boards (IRBs) has grown exponentially.[1] Since many LMICs have 
limited capacity in research ethics and bioethics, there is widespread 
concern that without well-designed training programmess and 
substantive capacity-building initiatives there could be an increase in 
vulnerability to exploitative research.[2] Examining resource needs in 
Africa, researchers found that 97% of REC members believed they had 
inadequate training in ethics and management of HIV vaccine trials 
and 80% believed they had inadequate training in health research 
ethics.[3] 
Sub-Saharan Africa has an admirable history related to the estab-
lishment of RECs and protecting human subjects involved in research 
activities; several reports suggest that a majority of countries have 
some procedures in place for ethical reviews.[4,5] We do know from 
the Kass case study[4] that South Africa (SA) established a REC in 
1967 and at least eight other committees had been established since 
2002. That said, during this time period and beyond, the African 
scientific community has been challenged with a variety of ethical 
issues. These include, but are not limited to onerous REC workloads, 
inadequate training, more sophisticated research protocols requiring 
greater need for expert review, and lack of resources to secure 
appropriate ethical reviews.[6-9] Tanzanian researchers and ethics 
review committee members have expressed concerns about the 
vali dity of applying international ethical principles that may be seen 
as not in alignment with the Tanzanian culture.[10] There continues to 
be a need for bioethics training in Africa, especially in the context of 
vaccine trial preparedness, be it HIV, TB, malaria or any of the other 
major endemic health problems impacting morbidity and mortality. 
International investigators may face major challenges when doing 
research in Africa, and one of the first to arise is ensuring that ethical 
review of a study meets international guidelines (i.e. Declaration of 
Helsinki (2013), CIOMS International Ethical Guidelines for Biomedical 
Research Involving Human Subjects (2002), Good Clinical Practice, 
and the Federal regulations that apply to research sponsored by 
US government agencies). Challenges have also been encountered 
regarding the appropriate ethical handling of human specimens 
and research data that are sent from Africa to high-income countries 
for further processing and storage, especially since there is a lack of 
uniformity in regulations across country borders.[11] 
Building research capacity involves a critical focus on the REC; 
enhanced capacity will benefit not only REC members, but also all 
stakeholders including principal investigators, research sponsors, and 
host communities. Over the past 26 years, the Fogarty International 
Center, part of the US National Institutes of Health, has supported 
research ethics capacity throughout the world and especially in Africa; 
this has significantly broadened the literature related in the field.
[12-14] Some of the ethical areas that are generally not well developed 
include appropriate management of vulnerable populations, the 
powerful manifestations of conflict of interest, confusion regarding 
standards of care, and the role and responsibilities of the investigator.
[15] Beyond these areas, there is evidence that many African RECs have 
inadequate financial support and find it difficult, given the economic 
realities in their countries, to insist on more funding for committee 
education and administrative support.[7,16] Sociocultural and linguistic 
differences, compounded with variations in history, wealth, politics, 
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and power relations between cultures can be major roadblocks to 
building research capacity in any resource-limited setting, especially 
in sub-Saharan Africa.[17] 
As LMICs experience increases in research activities, it is important 
that funding institutions and the universities and/or organisations 
where the research will be conducted work collaboratively on ethical 
review matters so that delays do not adversely impact research 
progress. Indeed, the Institute of Medicine notes that duplicative 
review may actually adversely impact human subject protection.[1] 
Several options that could be considered include jointly developing 
stan dard operating procedures for international collaborative research 
that allow for parallel or simultaneous submission of protocols,[17] and 
using a central IRB (CIRB) for multicentre research whereby local IRBs 
may rely on the CIRB for primary review and only conduct a facilitative 
review if there are ethical issues related to local cultural norms.[18] It 
should be noted, too, that the use of electronic review management 
systems could streamline the IRB review process in African countries, 
perhaps supplementing the video-conference modality that was 
used for this project.
We believe it is critical that these issues need to be better under-
stood and incorporated into any research ethics capacity-building 
effort. Research can continue, but without continuing improvement of 
the research ethics infrastructure, any lessons learned from reviewing 
research may not be translated to consistent practice. The overall goal 
of our project was to establish new and strengthen existing expertise 
in IRB management and training among research scientists, faculty, 
healthcare providers and other professionals at Muhimbili University 
of Health and Allied Sciences (MUHAS) and throughout Tanzania.
The problem
The length of time involved in securing IRB/REC approval is an im-
por tant factor that investigators must consider when planning 
research in LMICs, and this must be incorporated in the time-line 
for research projects. At one SA REC during the period 1997 – 1999, 
388 research protocols were reviewed and the average turnaround 
time for processing a protocol was 96 days.[7] Through a needs 
assessment of 31 RECs across Africa, Nyika et al.[5] found that the average 
time for a protocol review was 2 months. Cleaton-Jones discusses 
issues related to the increase in both REC applications and complaints 
from researchers about the time involved in obtaining approval for 
research, much of which was due to staffing issues, revisions required 
for appli cations, etc., and addresses the need to estimate REC 
workloads and invest in staffing resources as approaches that could 
be used.[19,20] With new and evolving health crises such as the most 
recent Ebola virus disease (EVD)[21] and the current widespread Zika 
virus outbreaks, special guidance must be considered for rapid review 
and approval for treatment and research in this context. Further, 
this becomes an even more important issue when experimental 
drugs and/or vaccines are being used before they have been proven 
efficacious in humans, especially in countries whose RECs may not 
have dealt with such issues.[22] During this outbreak, the World Health 
Organization released multiple statements and other guidance 
related to the ethical criteria surrounding care and treatment – the 
one on 5 September 2014 offering four critical elements concerning 
treatment and research.[23]
Our approach to the problem
To improve the ethical and cultural competencies of the IRB/REC 
at both Dartmouth and MUHAS and streamline the otherwise 
serial protocol review and approval process, we organised ‘rapid 
review’ committees (RRC) at both institutions. Both of these RRCs 
had the appropriate expertise and members in attendance to 
review each protocol and were capable of exercising the authority 
of an IRB established under the Federal-Wide Assurance. New and/
or modifications of protocols for studies being done in Tanzania 
by researchers at Dartmouth and MUHAS were assigned to these 
commit tees for their review and approval. These studies involved 
a double-blind, randomised clinical trial of a vaccine being tested 
for the prevention of disseminated tuberculosis in HIV patients, and 
a study of hearing loss in HIV-positive and HIV-negative subjects. 
Five video-conference meetings were held between February 
2011 and March 2012. To accommodate for the difference in time 
zones (+8 hours in Tanzania), they began at 07h00 (USA) and 15h00 
(Tanzania) and lasted approximately 1.5 hours. These joint meetings, 
the first ever done at Dartmouth and MUHAS, were conducted at 
Dartmouth’s Center for the Advancement of Learning (DCAL) and 
the Tanzania Global Development Learning Center (TGLD), using 
state-of-the art facilities and equipment. Both DCAL and TGLD use 
the H.323 Protocols Suite technology that provides a foundation for 
audio, video, and data communications across IP-based networks, 
inclu ding the Internet. DCAL offers video-conference services to 
faculty and staff at no cost; the TGLD in Dar-es-Salaam charged a 
fee of USD 250 per session which, if not covered by grant funds or 
other means, could be prohibitively expensive for a LMIC. In 2014 
MUHAS acquired its own video-conference system that has been 
installed in a large modern room in the university library and these 
services are now available free of charge. This was an important step 
in strengthening the REC capacity at the institution.
The first video-conference was an introductory session for members 
to meet one another and discuss their respective procedures. For the 
other four sessions, a primary reviewer representing each committee 
was responsible for presenting a summary of the research protocol, 
its ethical issues, and leading the discussion that followed. The 
documents required by each committee (protocols, consent forms, 
etc.) were shared electronically 2 weeks in advance of each video-
conference. The agenda for each session included time for an assigned 
member of one of the committees to present a summary report of a 
journal article or other information, and lead a brief discussion 
as continuing ethics education. Consensus voting on approval or 
required study modifications took place during the video-conference 
and each committee was responsible for submitting individual letters 
to the PI of the studies that were reviewed. We did not seek ethics 
approvals from the committees since they had agreed to participate 
in the video-conferences as part of the grant activities, so they 
deemed ethical approval was not necessary.
Programme evaluation
An evaluation of the joint video-conference meetings was conducted 
using SurveyMonkey. Members of the rapid review committees 
at Dartmouth and MUHAS were asked to answer a series of ten 
questions. The questions and their responses are shown in Table 1.
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In summary, the evaluation found that the video-conference sessions 
were helpful to very helpful (100%); electronic document sharing was 
helpful and sufficient (93%); having primary reviewers at each site was 
appropriate (100%); and the continuing education component was 
very helpful (85%).
Lessons learned
The major benefits of these collaborative IRB video-conferences were 
identified as: 
• continuing ethics education reflecting the US and Tanzanian perspectives 
• live interactions and discussions of important research protocols 
in a timely fashion 
• an effective method for understanding committee differences, 
challenges, and perspectives on how reviews can be performed 
but achieve the same goals.  
One useful suggestion resulting from the project was to designate 
one video-conference for a discussion of the differences in US 
and Tanzanian committee approaches and priorities. The overall 
assessment by all participants was that collaborative video-
conferencing is a superior method for review of studies being 
conducted in disparate areas of the world and is especially effective 
in LMICs.
Table 1. Evaluation of the joint video-conference meetings, conducted using SurveyMonkey
Question Response
This series of joint video-conference review sessions was considered 
an innovative element of the work plan. How do you rate the sessions 
overall from an IRB/REC perspective?
43% said very helpful, 36% said helpful, and 21% said 
somewhat helpful 
All documents for the sessions were sent electronically. Was this the 
best way to share materials?
93% said yes
Did you have enough time to review the materials before the video-
conference?
93% said yes
A primary reviewer from Dartmouth and MUHAS was designated and 
he or she was responsible for presenting each committee’s discussion 
points. Was this useful?
100% said yes
Each video-conference included a time for continuing education. How 
would you rate this activity?
54% said very helpful, 31% said helpful, and 15% said somewhat 
helpful
Each video-conference was scheduled for 1.5 hours. Was this amount 
of time adequate to complete the agenda?
93% said yes and 7% suggested 2 hours would be better
What would you say was the most beneficial part of the sessions? The benefits of the continuing education discussions, the 
availability for live interaction, understanding the differences 
between the two committees, better understanding the 
challenges faced by researchers in Tanzania, ability to share 
perspectives from each IRB, seeing issues approached differently 
but achieving the same outcome
What would you say was the least beneficial part of these sessions? Making sure there is enough time for discussion of differences 
in approaches and priorities, expensive venture and donor 
dependent (so perhaps not practical), discussing only one 
proposal potentially not cost-effective, challenging logistics, time 
differences, travel time for MUHAS to get to the video-conference 
session
Would you like these video-conference meetings to continue,  
if funding were available?
93% said yes
Other comments? The groups were a little large – for optimal collaboration perhaps 
no more than five people at each site, ethical issues presented in 
the proposed research were not common to both committees, 
sessions did not seem to impact on IRB determinations, joint 
committee video-conferences a superior method of review for 
studies being conducted in disparate areas of the world, and 
reciprocal education or innovation needed by members of both 
committees
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